Chicago Partners Investment Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
7,873
-1,318
| -14% | -$178K | 0.03% | 382 |
|
|
2025
Q1 | $1.1M | Buy |
9,191
+5,408
| +143% | +$646K | 0.04% | 343 |
|
|
2024
Q4 | $510K | Buy |
3,783
+94
| +3% | +$12.7K | 0.02% | 507 |
|
|
2024
Q3 | $524K | Buy |
3,689
+1,159
| +46% | +$165K | 0.02% | 476 |
|
|
2024
Q2 | $374K | Sell |
2,530
-296
| -10% | -$43.8K | 0.01% | 540 |
|
|
2024
Q1 | $362K | Sell |
2,826
-23
| -0.8% | -$2.94K | 0.02% | 525 |
|
|
2023
Q4 | $384K | Buy |
2,849
+273
| +11% | +$36.8K | 0.02% | 486 |
|
|
2023
Q3 | $299K | Sell |
2,576
-206
| -7% | -$23.9K | 0.02% | 510 |
|
|
2023
Q2 | $354K | Buy |
2,782
+156
| +6% | +$19.9K | 0.02% | 496 |
|
|
2023
Q1 | $349K | Sell |
2,626
-182
| -6% | -$24.2K | 0.02% | 473 |
|
|
2022
Q4 | $383K | Buy |
+2,808
| New | +$383K | 0.02% | 435 |
|
|
2022
Q3 | – | Sell |
-3,660
| Closed | -$454K | – | 605 |
|
|
2022
Q2 | $454K | Buy |
3,660
+1,097
| +43% | +$136K | 0.03% | 351 |
|
|
2022
Q1 | $291K | Buy |
+2,563
| New | +$291K | 0.02% | 420 |
|
|
2018
Q4 | – | Sell |
-560
| Closed | -$57K | – | 598 |
|
|
2018
Q3 | $57K | Buy |
+560
| New | +$57K | 0.01% | 497 |
|